Glycolysis-related radiosensitivity signature for predicting radiotherapy response in breast cancer
Our study establishes glycolytic activity as a promising predictor of radiotherapy efficacy in BRCA patients and develops a novel radiosensitivity signature with potential clinical utility in guiding personalized treatment strategies.
Authors
- Tianwen Xu (ORCID: https://orcid.org/0000-0003-2519-8140)
- Linyan Huang
- Xuan Lin (ORCID: https://orcid.org/0000-0001-7216-1821)
- Shiyin Hu (ORCID: https://orcid.org/0000-0003-4602-6970)
- Jinzhi Lai
Institutions
- Fujian Medical University (CN)
- First Affiliated Hospital of Xiamen University (CN)
- Second Affiliated Hospital of Fujian Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-10-02
- DOI
- https://doi.org/10.3389/fimmu.2025.1638897
- Primary Topic
- Glutathione Transferases and Polymorphisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00